Neurology and the gastrointestinal system

Journal of Neurology Neurosurgery and Psychiatry

Volumn 65, Issue 3, 1998, Pages 291-300

  Perkin, G D ^a   Murray Lyon, I ^b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELIAC DISEASE; DYSPHAGIA; ENTERITIS; ESOPHAGUS ACHALASIA; EXTRAPYRAMIDAL SYNDROME; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HIRSCHSPRUNG DISEASE; HUMAN; INNERVATION; INTESTINE ABSORPTION; INTESTINE LIPODYSTROPHY; MUSCLE DISEASE; NEUROLOGY; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0031660465     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.65.3.291     Document Type: Review

References (93)

1. Goldblum JR, Whyte RI, Orringer MB, et al. Achalasia: a morphologic study of 42 resected specimens. Am J Surg Pathol 1994;18:327-37.
2. Aggestrup S, Uddman R, Sundler F, et al. Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology 1983;84:924-7.
3. Bodian M, Stephens FD, Ward BCH. Hirschsprung's disease and idiopathic megacolon. Lancet 1949;256:6-11.
4. Gibson AAM, Young DG. Diagnosis of Hirschsprung's disease. Lancet 1975;ii:1149.
5. Boston VE, Dale G, Riley KWA, Diagnosis of Hirschsprung's disease by quantitative biochemical assay of acetylcholinesterase in rectal tissue. Lancet 1975;ii:951-3.
6. Schofield D, Devine W, Yunis EJ. Acetylcholinesterase - stained section rectal biopsies in the diagnosis of Hirschsprung's disease. J Pediatr Gastroenterol Nutr 1990;11:221-8.
7. Buchholz DW. Dysphagia associated with neurological disorders. Acta Oto-rhinolaryngol Belg 1994;48:143-55.
8. Chen MYM, Peele VN, Donalti D, et al. Clinical and videofluoroscopic evaluation of swallowing in 41 patients with neurologic disease. Gastrointest Radiol 1992;17:95-8.
9. Robbins J, Levine RL, Maser A, et al. Swallowing after unilateral stroke of the cerebral cortex. Arch Phys Med Rehabil 1993;74:1295-300.
10. Sumi T. Some properties of cortically evoked swallowing in rabbits. Brain Res 1969;15:107-20.
11. Hamdy S, Aziz Q, Rothwell JC, et al. The cortical topography of human swallowing musculature in health and disease. Nat Med 1996;2:1217-4.
12. Hamdy S, Aziz Q, Rothwell JC, et al. Explaining oropharyngeal dysphagia after unilateral hemispheric stroke. Lancet 1997;350:686-92.
13. Barer DH. The natural history and functional consequences of dysphagia after hemispheric stroke. J Neurol Neurosurg Psychiatry 1989;52:236-41.
14. Celifarco A, Gerard G, Faegenburg D, et al. Dysphagia as the sole manifestation of bilateral strokes. Am J Gastroenterol 1990;85:610-13.
15. Horner J, Buoyer FG, Alberts MJ, et al. Dysphagia following brain-stem stroke. Clinical correlates and outcome. Arch Neurol 1991;48:1170-3.
16. Bushmann M, Dobmeyer SM, Leeker L, et al. Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology 1989;39:1309-14.
17. Bird, MR, Woodward MC, Gibson EM, et al. Asymptomatic swallowing disorders in elderly patients with Parkinson's disease: a description of findings on clinical examination and videofluoroscopy in 16 patients. Age Ageing 1994;23: 251-4.
18. Neumann S, Reich S, Buchholz D. Progressive supranuclear palsy (PSP): characteristics of dysphagia in 14 patients. Dysphagia 1996;11:164.
19. Riski JE, Horner J, Nashold Jr BS. Swallowing function in patients with spasmodic torticollis. Neurology 1990;40: 1443-5.
20. Pollock IF, Pang D, Kocoshis S, et al. Neurogenic dysphagia resulting from Chiari malformations. Neurosurgery 1992; 30:709-19.
21. Achiron A, Kuritzky A. Dysphagia as the sole manifestation of adult type I Arnold-Chiari malformation. Neurology 1990;40:186-7.
22. Ikusaka M, Iwata M, Sasaki S, et al. Progressive dysphagia due to adult Chiari malformation mimicking amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1996;60: 357-8.
23. Robbins J. Swallowing in ALS and motor neuron disorders. Neurol Clin 1987;5:213-29.
24. Murray JP. Deglutition in myasthenia gravis. Br J Radiol 1962;35:43-52.
25. Metheny JA. Dermatomyositis: a vocal and swallowing disease entity. Laryngoscope 1978;88:147-61.
26. Dietz F, Logeman JA, Sahgal V, et al. Cricopharyngeal muscle dysfunction in the differential diagnosis of dysphagia in polymyositis. Arthritis Rheum 1980;23:491-5.
27. Riminton DS, Chambers ST, Parkin PJ, et al. Inclusion body myositis presenting solely as dysphagia. Neurology 1993;43: 1241-3.
28. Pierce JW, Creamer B, MacDermot V. Pharynx and oesophagus in dystrophia myotonica. Gut 1965;6:392-5.
29. Hughes DTD, Swann JC, Gleeson JA, et al. Abnormalities in swallowing associated with dystrophia myotonica. Brain 1965;88:1037-42.
30. Nowak TV, Ionasecu V, Anuras S. Gastrointestinal manifestations of the muscular dystrophies. Gastroenterology 1982; 82:800-10.
31. Duranceau AC, Beauchamp G, Jamieson GG, et al. Oropharyngeal dysphagia and oculopharyngeal muscular dystrophy. Surg Clin North Am 1983;63:825-32.
32. Victor M, Hayes R, Adams RD. Oculopharyngeal muscular dystrophy. A familial disease of late life characterised by dysphagia and progressive ptosis of the eyelids. N Engl J Med 1962;267:1267-72.
33. Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983;98:378-84.
34. Camilleri M, Malagelada J-R. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984;14:420-7.
35. Horowitz M, McNeil JD, Maddern GJ, et al. Abnormalities of gastric and esophageal emptying in polymyositis and dermatomyositis. Gastroenterology 1986;90:434-9.
36. Horowitz M, Maddox A, Maddern GJ, et al. Gastric and esophageal emptying in dystrophia myotonica. Effect of metoclopramide. Gastroenterology 1987;92:570-7.
37. Goldberg HI, Sheft DJ. Esophageal and colon changes in myotonia dystrophica. Gastroenterology 1972;63:134-9.
38. Brunner HG, Hamel BCJ, Rieu P, et al. Intestinal pseudo-obstruction in myotonic dystrophy. J Med Genet 1992;29:791-3.
39. Schuster MM, Tow DE, Sherbourne DH. Anal sphincter abnormalities characteristic of myotonic dystrophy. Gastroenterology 1965;49:641-8.
40. Leon SH, Schuffler MD, Kettler M, et al. Chronic intestinal pseudoobstruction as a complication of Duchenne's muscular dystrophy. Gastroenterology 1986;90:455-9.
41. Tefferi A, Pruthi RK. The biochemical basis of cobalamin deficiency. Mayo Clin Proc 1994;69:181-6.
42. Healton EB, Savage DG, Brust JCM, et al. Neurologic aspects of cobalamin deficiency. Medicine 1991;70:229-45.
43. Gautier-Smith PC. Lhermitte's sign in subacute combined degeneration of the cord. J Neurol Neurosurg Psychiatry 1973;36:861-3.
44. 12 deficiency. Am J Ophthalmol 1977;83:465-8.
45. Perkin GD, Roche SW, Abraham R. Delayed somatosensory evoked potentials in pernicious anaemia with intact peripheral nerves. J Neurol Neurosurg Psychiatry 1989;52: 1017-18.
46. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988;318:1720-8.
47. 12 with normal blood and marrow. Q J Med 1965;34:303-17.
48. Ebels EJ. How common is Wernicke-Korsakoff syndrome? Lancet 1978;ii:781-2.
49. Handler CE, Perkin GD. Anorexia nervosa and Wernicke's encephalopathy: an underdiagnosed association. Lancet 1982;ii:771-2.
50. Perkin GD, Handler CE. Wernicke-Korsakoff syndrome. Br J Hosp Med 1983;30:331-4.
51. Cravioto H, Korein J, Silberman J. Wernicke's encephalopathy. A clinical and pathological study of 28 autopsied cases. Arch Neurol 1961;4:510-19.
52. Tabaqchali S, Pallis C. Reversible nicotinamide-deficiency encephalopathy in a patient with jejunal diverticulosis. Gut 1970;11:1024-8.
53. Serdaru M, Hausser-Hauw C, Laplane D, et al. The clinical spectrum of alcoholic pellagra encephalopathy. Brain 1988; 111:829-42.
54. Prineas JW, Mason AS, Henson RA. Myopathy in metabolic bone disease. BMJ 1965;1:1034-6.
55. Smith R, Stern G. Myopathy, osteomalacia and hyperparathyroidism. Brain 1967;90:593-602.
56. Kayden HJ, The neurologic syndrome of vitamin E deficiency: a significant cause of ataxia. Neurology 1993;43: 2167-9.
57. Traber MG, Sokol RJ, Ringel SP, et al. Lack of tocopherol in peripheral nerves of vitamin E-deficient patients with peripheral neuropathy. N Engl J Med 1987;317:262-5.
58. Miller RG, Davis CJF, Illingworth DR, et al. The neuropathy of abetalipoproteinaemia. Neurology 1980;30: 1286-91.
59. Muller DPR, Lloyd JK, Wolff OH. Vitamin E and neurological function. Lancet 1983;i:225-8.
60. Harding AE, Muller DPR, Thomas PK, et al. Spinocerebellar degeneration secondary to chronic intestinal malabsorption. A vitamin E deficiency syndrome. Ann Neurol 1982;12:419-24.
61. Burck U, Goebel HH, Kuhlendahl HD, et al. Neuromyopathy and vitamin E deficiency in man. Neuropaediatrics 1981;12:267-78.
62. Hamida MB, Belal S, Sirugo G, et al. Friedreich's ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamin E deficiency in two inbred Tunisian families. Neurology 1993;43:2179-83.
63. Kinney HC, Burger PC, Hurwitz BJ, et al. Degeneration of the central nervous system associated with celiac disease. J Neurol Sci 1982;53:9-22.
64. Banerji NK, Hurwitz LJ. Neurological manifestations in adult steatorrhoea. (Probable gluten enteropathy). J Neurol Sci 1971;14:125-41.
65. Cooke WT, Smith WT. Neurological disorders associated with adult coeliac disease. Brain 1966;86:683-718.
66. Collin P, Mäki M. Associated disorders in coeliac disease: clinical aspects. Scand J Gastroenterol 1994;29:769-75.
67. Kritoferitsch W, Pointner H. Progressive cerebellar syndrome in adult coeliac disease. J Neurol 1987;234:116-18.
68. Ward ME, Murphy JT, Greenberg GR. Coeliac disease and spinocerebellar degeneration with normal vitamin E status. Neurology 1985;35:1199-201.
69. Chapman RWG, Laidlow JM, Colin-Jones D, et al. Increased prevalence of epilepsy in coeliac disease. BMJ 1978;ii:250-1.
70. Gobbi G, Bouquet F, Greco L, et al. Coeliac disease, epilepsy, and cerebral calcifications. Lancet 1992;340:439-43.
71. Dickey W. Epilepsy, cerebral calcifications, and coeliac disease. Lancet 1994;344:1585-6.
72. Borda IT, Southern RF, Brown WF. Cerebral venous thrombosis in ulcerative colitis. Gastroenterology 1973;64: 116-19.
73. Graef V, Baggenstoss AH, Sauer WG, et al. Venous thrombosis occurring in nonspecific ulcerative colitis. A necropsy study. Arch Intern Med 1966;117:377-82.
74. Conlan MF, Hire WD, Burnett DA. Prothrombotic abnormalities in inflammatory bowel disease. Dig Dis Sci 1989;34:1089-93.
75. Slot WB, Van Kasteel V, Coerkamp EG, et al. Severe thrombotic complications in a postpartum patient with active Crohn's disease resulting in ischemic spinal cord injury. Dig Dis Sci 1995;40:1395-9.
76. Wills A, Hovell CJ. Neurological complications of enteric disease. Gut 1996;39:501-4.
77. Nemni R, Fazio R, Corbo M, et al. Peripheral neuropathy associated with Crohn's disease. Neurology 1987;37:1414-17.
78. Losses A, River Y, Eliakim A, et al. Neurologic aspects of inflammatory bowel disease. Neurology 1995;45:416-21.
79. Leibowitz G, Eliakim R, Amir G, et al. Dermatomyositis associated with Crohn's disease. J Clin Gastroenterol 1994;18:48-52.
80. Geissler A, Andus T, Roth M, et al. Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet 1995;345:897-8.
81. Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Johns Hopkins Hospital Bulletin 1907;18:382-91.
82. Fredricks DN, Relman DA. Cultivation of Whipple bacillus: the irony and the ecstasy. Lancet 1997;350:1262-3.
83. Keren DF, Weisburger WR, Yardley JH, et al. Whipple's disease: demonstration by immunofluorescence of similar bacterial antigens in macrophages from three cases. Johns Hopkins Medical Journal 1976;139:51-9.
84. Relman DA, Schmidt TM, MacDermott RP, et al. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992;327:293-301.
85. Schoedon G, Goldenberger D, Forrer R, et al. Deactivation of macrophages with IL-4 is the key to the isolation of Tropheryma Whippelii. J Infect Dis 1997;176:672-7.
86. Keren DF. Whipple's disease: the causative agent defined. Its pathogenesis remains obscure. Medicine (Baltimore) 1993;72:355-8.
87. Sieracki JC. Whipple's disease: observations on systemic involvement. AMA Arch Pathol 1958;66:464-7.
88. Badenoch J, Richards WCD, Oppenheimer DR. Encephalopathy in a case of Whipple's disease. J Neurol Neurosurg Psychiatry 1963;26:203-10.
89. Romanul FCA, Radvany J, Rosales RK. Whipple's disease confined to the brain: a case studied clinically and pathologically. J Neurol Neurosurg Psychiatry 1977;40:901-9.
90. Adams M, Rhyner PA, Day J, et al. Whipple's disease confined to the central nervous system. Ann Neurol 1987;21:104-8.
91. Knox DL, Green WR, Troncoso JC, et al. Cerebral ocular Whipple's disease: a 62-year odyssey from death to diagnosis. Neurology 1995;45:617-25.
92. Dobbins WO. The diagnosis of Whipple's disease. N Engl J Med 1995;332:390-2.
93. Schnider P, Trattnig S, Kollegger H, et al. MR of cerebral Whipple's disease. AJNR Am J Neuroradiol 1995;16:1328-9.